JB Pharma to acquire the Razel franchise for Rs 314 crore
The acquisition marks JB Pharma’s entry into 'statin’ segment which is the largest group in the cardiac therapy
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
JB Pharma
US FDA approves JB Pharma’s generic Venlafaxine extended-release tablets
The product is based on Osmotic Controlled Release Oral Delivery System (OROS) technology, an advanced and precision controlled…
JB Pharma records revenue growth of 36 per cent to Rs 809 crore in Q2 FY23
Operating EBITDA grew by 44 per cent to Rs 202 crore
JB Pharma commits to ESG in its maiden Sustainability Report
The sustainability report is for the year FY 2021-2022 based on the international reporting standards framework, Global Reporting…
JB Pharma registers impressive numbers for FY2021-22
The company has registered operating revenues at Rs 2,424 crore and EBITDA at Rs 550 crore
JB Pharma records revenue growth of 30 per cent to Rs 785 crore in Q1FY23
Operating EBITDA grows by 16 per cent to Rs 190 crore
JB Pharma acquires four paediatric brands from Dr Reddy’s Laboratories
The total covered market size of four brands – Z&D, Pedicloryl, Pecef and Ezinapi combined is Rs 1800 crores